These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18847250)

  • 1. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
    Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.
    Shah JR; Mosier PD; Roth BL; Kellogg GE; Westkaemper RB
    Bioorg Med Chem; 2009 Sep; 17(18):6496-504. PubMed ID: 19700330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor.
    Dewkar GK; Peddi S; Mosier PD; Roth BL; Westkaemper RB
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5268-71. PubMed ID: 18774714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
    Shah JR; Mosier PD; Peddi S; Roth BL; Westkaemper RB
    Bioorg Med Chem Lett; 2010 Feb; 20(3):935-8. PubMed ID: 20045641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
    Runyon SP; Peddi S; Savage JE; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2002 Apr; 45(8):1656-64. PubMed ID: 11931619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
    Peddi S; Roth BL; Glennon RA; Westkaemper RB
    Eur J Pharmacol; 2003 Dec; 482(1-3):335-7. PubMed ID: 14660041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
    Westkaemper RB; Glennon RA
    Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
    Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
    Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
    Peddi S; Roth BL; Glennon RA; Westkaemper RB
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2565-8. PubMed ID: 12852967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
    Westkaemper RB; Runyon SP; Savage JE; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2001 Feb; 11(4):563-6. PubMed ID: 11229772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
    Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB
    Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
    Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
    J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.
    Rangisetty JB; Dukat M; Dowd CS; Herrick-Davis K; DuPre A; Gadepalli S; Teitler M; Kelley CR; Sharif NA; Glennon RA
    J Med Chem; 2001 Sep; 44(20):3283-91. PubMed ID: 11563927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype.
    Bruno A; Beato C; Costantino G
    Future Med Chem; 2011 Apr; 3(6):665-81. PubMed ID: 21554074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.
    Kramer V; Herth MM; Santini MA; Palner M; Knudsen GM; Rösch F
    Chem Biol Drug Des; 2010 Oct; 76(4):361-6. PubMed ID: 20636331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.